Home | Add Company | Subscribe | Search | Contact

BioPharmaLink

 

Login

Directory:

Add Company

Your company can benefit from enhanced listings. Questions? Read our FAQ first.

 

Personalized notification service and newsletter info

Subscribe (free) to get notified of new additions.

 

Learn more About us and about our Services

 

Contact us

New technology

HEALTHPOINT® Launches OASIS® Burn Matrix

Concerns: technology
Released on: 09-Apr-2003

Pharmaceutical form and dosage: Biomaterial

Active substances / mechanism: Natural, extracellular matrix used to manage partial and full-thickness wounds.


Type:

- Curative
- Drug delivery
- FP (finished products)
- Pharmaceuticals / Therapeutics
- Prescription drugs (Rx)


Therapeutic target:

- Dermatology
- Epidemiology
- Infectious Diseases
- Men's Health
- Pain
- Pediatrics
- Women's Health


Concerns the following market:
- United States of America

See also:


Company Profile: Healthpoint, Ltd., a DFB Pharmaceuticals Company
United States of America

Contact for this news release: Jay Nisbet

Or check this company's:



Full Description:
(Fort Worth, TX, USA) — HEALTHPOINT, Ltd., a market leader in pharmaceutical products for skin and soft tissues, is pleased to announce the availability of the OASIS Burn Matrix, a product that provides a supportive environment to allow healing of second degree and superficial burns.

An initial launch took place during HEALTHPOINT’S National Sales Meeting in Dallas in March, with nationwide launch this week.

The OASIS Burn Matrix complements the OASIS Wound Matrix line of products marketed and distributed exclusively by HEALTHPOINT and manufactured by Cook Biotech.

The OASIS Burn Matrix was designed with several features specifically for burn patients, including increased thickness of the OASIS Burn Matrix that may allow application for an extended time. As frequency of application decreases, less pain may result since repeated dressing changes are often increasingly painful for burn patients.

“OASIS Burn Matrix sets a new standard for the management of donor sites as well as for second degree and superficial burns,” said Dwayne Dixon, Tissue Management Marketing Director. “This provides a new option for patients suffering the effects of serious burns.”

Since its inception in 1992, HEALTHPOINT has established a national presence in the research, development, and marketing of branded pharmaceuticals, over the counter drugs, and medical devices for the tissue management, dermatology, and surgical divisions. An aggressive research and development effort has brought HEALTHPOINT’s unique technologies to the market, setting the pace for its highly trained national field sales organization of direct sales representatives. HEALTHPOINT, with over 250 employees, is a DFB Pharmaceuticals, Inc. affiliate company.

HEALTHPOINT has an additional office in Canada. Visit HEALTHPOINT’s web site at www.healthpoint.com.

###


  Contact for this news release: Jay Nisbet


Suggestion box | Disclaimer | Privacy Policy | Rules & Regulations
Copyright© Cofidei, Inc. - Page last modified: 09-Apr-2003.

Home | Add Company | Subscribe to Newsletter | Search Companies | Search Offers | Power search